Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis
Public ClinicalTrials.gov record NCT00694135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multi-Center, Randomized, Double-Masked, Safety, Tolerability and Efficacy Study of Four Iontophoretic Doses of Dexamethasone Phosphate Ophthalmic Solution in Patients With Non-Infectious Anterior Segment Uveitis
Study identification
- NCT ID
- NCT00694135
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eyegate Pharmaceuticals, Inc.
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- EGP-437 1.6 mA-min at 0.4 with EyeGate® II System Drug
- EGP-437 4.8 mA-min at 1.2 mA with EyeGate® II System Drug
- EGP-437 10.0 mA-min at 2.5 mA with EyeGate® II System Drug
- EGP-437 14.0 mA-min at 3.5 mA with EyeGate® II System Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Jun 30, 2009
- Completion
- Jul 31, 2009
- Last update posted
- Aug 30, 2010
2008 – 2009
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | — |
| Emory Eye Center | Atlanta | Georgia | 30322 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Massachusetts Eye Research and Surgery Institution | Cambridge | Massachusetts | 02142 | — |
| Comprehensive Eye Care Ltd. | Washington | Missouri | 63090 | — |
| New York Eye & Ear Infirmary | New York | New York | 10003 | — |
| Cleveland Eye Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health Services University | Portland | Oregon | 97239 | — |
| Pennsylvania College of Optometry | Elkins Park | Pennsylvania | 19027 | — |
| Scheie Eye Institue | Philadelphia | Pennsylvania | 19104 | — |
| Southern College of Optometry | Memphis | Tennessee | 38104 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Virginia Eye Consultants | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00694135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2010 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00694135 live on ClinicalTrials.gov.